Pancreatic islet transplantation in the treatment of diabetes mellitus.

This chapter reviews current developments and future directions in clinical islet transplantation. With the recent introduction of glucocorticoid-free immunosuppressive therapies and improved methods for islet isolation, the success of the procedure has increased substantially. Challenges ahead include progress with international multicentre trials, development of single donor protocols, progress in clinical tolerance based therapies to lower overall risk of immunosuppression, and ultimately finding an alternative source to provide effective therapy for more patients with diabetes. Recent advances in stem cell biology and xenotransplantation may soon provide this opportunity.

[1]  L. Turka,et al.  Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction. , 2000, Transplantation.

[2]  J. Jeekel,et al.  SUPPRESSION OF ACUTE REJECTION PREVENTS GRAFT ARTERIOSCLEROSIS AFTER ALLOGENEIC AORTA TRANSPLANTATION IN THE RAT , 1994, Transplantation.

[3]  G. L. Engel,et al.  Do retrospective and prospective quality of life assessments differ for pancreas-kidney transplant recipients? , 1998, Transplant international : official journal of the European Society for Organ Transplantation.

[4]  C. Ricordi,et al.  Acceleration of chronic failure of intrahepatic canine islet autografts by a short course of prednisone. , 1994, Transplantation.

[5]  P. Pozzilli,et al.  Cell-mediated immune response to β casein in recent-onset insulin-dependent diabetes: implications for disease pathogenesis , 1996, The Lancet.

[6]  Schulak Ja,et al.  Experimental pancreas allograft rejection: correlation between histologic and functional rejection and the efficacy of antirejection therapy. , 1985 .

[7]  E. Ryan.  Pancreas transplants: for whom? , 1998, The Lancet.

[8]  J. Najarian,et al.  Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. , 1990, The New England journal of medicine.

[9]  E. Woodle,et al.  Comparison of pancreas transplantation with portal venous and enteric exocrine drainage to the standard technique utilizing bladder drainage of exocrine secretions. , 1996, Transplantation.

[10]  J. Todd.  Genetic analysis of type 1 diabetes using whole genome approaches. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Zand,et al.  Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment. , 1998, Transplantation.

[12]  J. Najarian,et al.  Living versus cadaver donor pancreas transplants. , 1998, Transplantation Proceedings.

[13]  J. Lakey,et al.  Evaluation of a purified enzyme blend for the recovery and function of canine pancreatic islets. , 1998, Cell transplantation.

[14]  A. Sheil,et al.  Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance. , 1999, Transplantation.

[15]  D. Nathan,et al.  Long-term complications of diabetes mellitus. , 1993, The New England journal of medicine.

[16]  J. Krischer,et al.  A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. , 1990, The New England journal of medicine.

[17]  M. Suarez‐Almazor,et al.  Variables in organ donors that affect the recovery of human islets of Langerhans. , 1996, Transplantation.

[18]  J. Bowker,et al.  Impaired Vibratory Perception and Diabetic Foot Ulceration , 1986, Diabetic medicine : a journal of the British Diabetic Association.

[19]  R. Calne,et al.  Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. , 1999, Transplantation.

[20]  P. Kuo,et al.  Simultaneous pancreas/kidney transplantation--a comparison of enteric and bladder drainage of exocrine pancreatic secretions. , 1997, Transplantation.

[21]  Tom H. Lindner,et al.  Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus , 2000, Nature Genetics.

[22]  T. Songer,et al.  Hew Many People in the U.S. Have IDDM? , 1993, Diabetes Care.

[23]  C. Ricordi,et al.  Improved Human Islet Isolation Using a New Enzyme Blend, Liberase , 1997, Diabetes.

[24]  J. Wallwork,et al.  Life supporting function for over one month of a transgenic porcine heart in a baboon. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[25]  S. Paraskevas,et al.  Cell Loss in Isolated Human Islets Occurs by Apoptosis , 2000, Pancreas.

[26]  M. Markell.  Post-transplant diabetes: incidence, relationship to choice of immunosuppressive drugs, and treatment protocol. , 2001, Advances in renal replacement therapy.

[27]  P. Bennett,et al.  Prevalence of Diabetes and Impaired Glucose Tolerance and Plasma Glucose Levels in U.S. Population Aged 20–74 Yr , 1987, Diabetes.

[28]  K. Narayan,et al.  Type 2 diabetes in children , 2001, BMJ : British Medical Journal.

[29]  J. Flier,et al.  Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. , 1987, The New England journal of medicine.

[30]  B. Torbett,et al.  Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice , 2000, Nature.

[31]  R. P. Robertson,et al.  Hepatic Insulin Resistance After Pancreas Transplantation in Type I Diabetes , 1996, Diabetes.

[32]  J. Contreras,et al.  Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy. , 2000, Transplantation.

[33]  C Meyerhoff,et al.  Subcutaneous Glucose Concentration in Humans: Real estimation and continuous monitoring , 1995, Diabetes Care.

[34]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[35]  G. Korbutt,et al.  Glucose-dependent insulin release from genetically engineered K cells. , 2000, Science.

[36]  I. Bekersky,et al.  Combined effect of rapamycin and FK 506 in prolongation of small bowel graft survival in the mouse. , 1998, Transplantation proceedings.

[37]  D. Harlan,et al.  Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[38]  W. Rau,et al.  Improved survival of intraportal pancreatic islet cell allografts in patients with type-1 diabetes mellitus by refined peritransplant management , 1999, Journal of Molecular Medicine.

[39]  G. Elgue,et al.  Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? , 1999, Diabetes.

[40]  O. Khalil,et al.  Spectroscopic and clinical aspects of noninvasive glucose measurements. , 1999, Clinical chemistry.

[41]  Hyun Chul Lee,et al.  Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue , 2000, Nature.

[42]  L. Luzi.  Metabolic strategies to predict and improve intrahepatic islet graft function , 1999, Journal of Molecular Medicine.

[43]  S. Bonner-Weir,et al.  In vitro cultivation of human islets from expanded ductal tissue. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Yasuhiro Takeuchi,et al.  Infection of human cells by an endogenous retrovirus of pigs , 1997, Nature Medicine.

[45]  P. Morel,et al.  Long-term metabolic results after pancreatic resection for severe chronic pancreatitis. , 2000, Archives of surgery.

[46]  S. Sehgal,et al.  Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. , 1975, The Journal of antibiotics.

[47]  D. Dunn,et al.  Long-term quality of life after kidney and simultaneous pancreas-kidney transplantation. , 1998, Clinical transplantation.

[48]  F. Delmonico,et al.  Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. , 1999, Transplantation.

[49]  Z. Leitner.  Cholesterol and Vascular Disease , 1956 .

[50]  Bartlett St.  Pancreatic transplantation after thirty years: still room for improvement. , 1996 .

[51]  G. Hitman,et al.  Diabetes. Exploding type II. , 1998, The Lancet.

[52]  C. Gross,et al.  Quality of life after pancreas transplantation: a review. , 1998, Clinical transplantation.

[53]  D. Finegood,et al.  The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients. , 1996, Transplantation.

[54]  P. Lacy,et al.  Sensitization to HLA antigens in islet recipients with failing transplants. , 1997, Transplantation proceedings.

[55]  M. Field,et al.  Detrimental effect of prednisone on canine islet autograft function. , 1992, Transplantation proceedings.

[56]  S. Knechtle,et al.  Indications for enteric conversion after pancreas transplantation with bladder drainage. , 1992, Surgery.

[57]  Lars Bäckman,et al.  INTERLEUKIN-2-RECEPTOR BLOCKADE WITH DACLIZUMAB TO PREVENT ACUTE REJECTION IN RENAL TRANSPLANTATION , 1998 .

[58]  S. Busque,et al.  Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat. , 1997, Transplantation.

[59]  C. Ricordi,et al.  Liver-islet transplantation in type 2 diabetes. , 1997, Transplantation proceedings.

[60]  A. Humar,et al.  Living related donor pancreas and pancreas-kidney transplantation. , 1997, British medical bulletin.

[61]  Michael Bliss,et al.  The Discovery of Insulin , 1982 .

[62]  A. Pugliese.  Unraveling the genetics of insulin-dependent type 1A diabetes: The search must go on , 1999 .

[63]  B. Hering,et al.  International islet transplant registry report , 1996 .

[64]  F C Goetz,et al.  Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. , 1967 .

[65]  P. Lacy,et al.  The use of ficoll in the preparation of viable islets of langerhans from the rat pancreas. , 1973, Transplantation.

[66]  G. Hitman,et al.  Exploding type II , 1998, The Lancet.

[67]  D. Harlan,et al.  CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[68]  B. Woda,et al.  Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice. , 2000, Blood.

[69]  J. Cameron,et al.  Portal hypertension, hepatic infarction, and liver failure complicating pancreatic islet autotransplantation. , 1982, Surgery.

[70]  J. Contreras,et al.  Long-term functional islet mass and metabolic function after xenoislet transplantation in primates. , 2000, Transplantation.

[71]  Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries: A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study , 2001 .

[72]  V. Fuster,et al.  Modulation of apoptosis, proliferation, and p27 expression in a porcine coronary angioplasty model. , 2000, Atherosclerosis.

[73]  D. Kendall,et al.  Pancreas Transplantation Restores Epinephrine Response and Symptom Recognition During Hypoglycemia in Patients With Long-Standing Type I Diabetes and Autonomic Neuropathy , 1997, Diabetes.

[74]  P. Kuo,et al.  Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy. , 1996, Annals of surgery.

[75]  Joshua Miller,et al.  A Comparison Of Tacrolimus (fk506) And Cyclosporine For Immunosuppression After Cadaveric Renal Transplantation1 , 1997 .

[76]  F. Vincenti,et al.  Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis , 2000, Transplant international : official journal of the European Society for Organ Transplantation.

[77]  M. W. Flye,et al.  Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolong rat cardiac allograft survival. , 1990, Surgery.

[78]  A. Amos,et al.  The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010 , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[79]  C. Warlow.  Epidemiology of stroke , 1998, The Lancet.

[80]  J. Farndon,et al.  Comparison of harvesting methods for islet transplantation , 1986, The British journal of surgery.

[81]  B. Kahan.  Cyclosporin A, FK506, rapamycin: the use of a quantitative analytic tool to discriminate immunosuppressive drug interactions. , 1992, Journal of the American Society of Nephrology : JASN.

[82]  M. Berger.  Pancreas Transplantation for Patients With Diabetes Mellitus , 1993, Diabetes Care.

[83]  Y Takeuchi,et al.  Infection of Nonhuman Primate Cells by Pig Endogenous Retrovirus , 2000, Journal of Virology.

[84]  T. Strom,et al.  Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance , 1999, Nature Medicine.

[85]  Normalization of insulin sensitivity and glucose homeostasis in type I diabetic pancreas transplant recipients: a 48-month cross-sectional study--a clinical research center study. , 1996, The Journal of clinical endocrinology and metabolism.

[86]  J. Ilonen,et al.  A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. , 1992 .

[87]  B. Kennedy,et al.  Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. , 1999, Science.

[88]  D. Kendall,et al.  Simultaneous pancreas-kidney transplantation from live donors. , 1997, Annals of surgery.

[89]  R. James,et al.  Large-Scale Purification of Human Islets Utilizing Discontinuous Albumin Gradient on IBM 2991 Cell Separator , 1989, Diabetes.

[90]  A. Ziegler,et al.  Predicting Type I Diabetes , 1990, Diabetes Care.

[91]  O. Korsgren,et al.  Isolated Human Islets Trigger an Instant Blood Mediated Inflammatory Reaction: Implications for Intraportal Islet Transplantation as a Treatment for Patients with Type 1 Diabetes , 2000, Upsala journal of medical sciences.

[92]  J. Reig,et al.  Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. , 2000, Diabetes.

[93]  P. Lacy,et al.  Islet purification using Euro-Ficoll gradients. , 1991, Transplantation proceedings.

[94]  E. Ryan,et al.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. , 2000, The New England journal of medicine.

[95]  M. Flye.  Principles of Organ Transplantation , 2002 .

[96]  D. Harlan,et al.  Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates , 1999, Nature Medicine.

[97]  D. Kendall,et al.  Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis. , 2001, Diabetes.

[98]  S. Sehgal,et al.  Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.:II. FERMENTATION, ISOLATION AND CHARACTERIZATION , 1975 .

[99]  D. Finegood,et al.  PROLONGATION OF CANINE PANCREATIC ISLET ALLOGRAFT SURVIVAL WITH COMBINED RAPAMYCIN AND CYCLOSPORINE THERAPY AT LOW DOSES: RAPAMYCIN EFFICACY IS BLOOD LEVEL RELATED1 , 1993, Transplantation.

[100]  Barry D Kahan,et al.  Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study , 2000, The Lancet.

[101]  X. Qin,et al.  Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters. , 1997, The Journal of clinical investigation.

[102]  Zu-hua Gao,et al.  From the Selectedworks of Vivian C. Mcalister Sirolimus-tacrolimus Combination Immunosuppression , 2022 .

[103]  A. Veves,et al.  Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. , 1991, Diabetes research and clinical practice.